Clinical Trial Update: A Clinical Research of CD123-Targeted CAR-T in Myeloid Malignancies [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for a CD123-targeted CAR-T therapy in myeloid malignancies across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Drugs mentioned

• CD123-targeted CAR-T (CD123-targeted CAR-T)

Snippet

Sponsor: Southwest Hospital, China | Conditions: Leukemia | Phase 1, Phase 2 | Status: UNKNOWN